Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2021 | editorial

European Society for Medical Oncology 2020

verfasst von: Dr. Rupert Bartsch

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Auszug

The 2020 Congress of the European Society for Medical Oncology (ESMO) was another large meeting held solely in a virtual format due to the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. While we all have—to a certain extent—become used to the transfer of large parts of our professional lives into the virtual world, following developments outside our own field of expertise has become more difficult. Therefore, reviews focusing on congress highlights have gained importance and in the current issue, the Magazine of European Medical Oncology (MEMO) provides a series of articles focusing on relevant results presented at the virtual 2020 ESMO congress in the fields of breast cancer, non-small-cell lung cancer (NSCLC), gastrointestinal and genitourinary cancers. …
Vorheriger Artikel Treatment approaches towards physical activity – malnutrition – cognitive impairment
Nächster Artikel Neuro-oncology 2021
Literatur
1.
2.
3.
4.
Metadaten
Titel
European Society for Medical Oncology 2020
verfasst von
Dr. Rupert Bartsch
Publikationsdatum
01.06.2021
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2021
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-021-00712-6

Weitere Artikel der Ausgabe 2/2021

DNA methylation as predictive marker of response to immunotherapy?

  • Open Access
  • short review

Unique gastrointestinal stromal tumor with PDGFRA D842Y mutation—evaluation of in vivo sensitivity to imatinib

  • case report

Immunotherapy revisited

  • editorial

ESMO virtual congress 2020—highlights NSCLC

  • Open Access
  • short review

Novel immune checkpoints beyond PD-1 in advanced melanoma

  • Open Access
  • short review

CAR T cell therapy in solid tumors: a short review

  • Open Access
  • review